{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/en\/","title":"In COPD, Renewed Emphasis on Symptom Control Provides Framework for Tailoring Therapy - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"vNiXZhXZKb\"><a href=\"https:\/\/themedicalxchange.com\/en\/2016\/05\/24\/american-thoracic-society-ats-2016-international-3\/\">In COPD, Renewed Emphasis on Symptom Control Provides Framework for Tailoring Therapy<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/en\/2016\/05\/24\/american-thoracic-society-ats-2016-international-3\/embed\/#?secret=vNiXZhXZKb\" width=\"600\" height=\"338\" title=\"&#8220;In COPD, Renewed Emphasis on Symptom Control Provides Framework for Tailoring Therapy&#8221; &#8212; The Medical Xchange\" data-secret=\"vNiXZhXZKb\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2016\/05\/2365_ATS_2016_slides_Fig1.PNG","thumbnail_width":960,"thumbnail_height":720,"description":"San Francisco \u2013 A debate at the 2016 ATS International Conference that centered on the value of initiating combination therapy in chronic obstructive pulmonary disease (COPD) provoked concern that key therapeutic objectives are being overlooked. As expressed in many guidelines, including those issued by the Canadian Thoracic Society, control of dyspnea and other major COPD symptoms is a critical goal. According to one participant in the debate, it is important not to confuse the established goals in COPD with theoretical gains."}